Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Study of Viralym-M (ALVR105) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant - Drug Trials For Money - Paid Clinical Trials

Study of Viralym-M (ALVR105) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Conditions: BK Virus Infection; JC Virus Infection; Epstein-Barr Virus Infections; Cytomegalovirus Infections; Adenovirus Infection; Human Herpes Virus-6 Infection
Interventions: Biological: Viralym-M Cells; Biological: Placebo (visually identical to Viralym-M)
Sponsor: AlloVir
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 6, 2021 / by ClinicalTrials.gov / in Oncology

Comments